Rebuttal: Evidence and uncertainties

Int J Tuberc Lung Dis. 2002 Aug;6(8):651-3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Communicable Disease Control* / economics
  • Directly Observed Therapy
  • Humans
  • Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

  • Antitubercular Agents